| NCT Number | NCT05223192 |
| Lead Sponsor | Icahn School of Medicine at Mount Sinai |
| Conditions | Prematurity |
| Enrollment | 120 participants |
| Start Date | 2022-04-01 |
| Primary Completion | 2026-12-31 (estimated) |
| Study Completion | 2026-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-13 |